On a global scale, vaccination of newborns and infants is well established and has developed a successful working infrastructure. The hepatitis B virus (HBV) vaccination programs offer a model for HPV introduction in which newborn and infant immunization achieves a rapid reduction in the prevalence of the HBV carrier rates in immunized cohorts of children, and of liver cirrhosis and liver cancer decades later. [Emphasis mine.]
They consider giving babies the hepatitis B vaccine on the day of birth to be a model for reducing the age of HPV vaccination. Rather than vaccinating girls shortly before or near puberty, they’re suggesting that they be vaccinated as infants. READ MORE…